{
  "DOI": "10.1007/s10689-016-9895-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-016-9895-3",
  "alternative-id": [
    "9895"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Ponti",
      "given": "Francesca",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Corsini",
      "given": "Serena",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gnoli",
      "given": "Maria",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pedrini",
      "given": "Elena",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mordenti",
      "given": "Marina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sangiorgi",
      "given": "Luca",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        3,
        8
      ]
    ],
    "date-time": "2016-03-08T05:12:25Z",
    "timestamp": 1457413945000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:19Z",
    "timestamp": 1559252779000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        11,
        1
      ]
    ],
    "date-time": "2022-11-01T07:34:17Z",
    "timestamp": 1667288057947
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2016,
        3,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2016,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            3,
            8
          ]
        ],
        "date-time": "2016-03-08T00:00:00Z",
        "timestamp": 1457395200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9895-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-016-9895-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9895-3",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "635-643",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        3,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        3,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1177/1947601911413466",
      "author": "D Malkin",
      "doi-asserted-by": "publisher",
      "first-page": "475",
      "issue": "4",
      "journal-title": "Cancer",
      "key": "9895_CR1",
      "unstructured": "Malkin D (2011) Li-Fraumeni syndrome. genes. Cancer 2(4):475–484. doi: 10.1177/1947601911413466",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.tig.2011.12.002",
      "author": "HC Reinhardt",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "issue": "3",
      "journal-title": "Trends Genet",
      "key": "9895_CR2",
      "unstructured": "Reinhardt HC, Schumacher B (2012) The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28(3):128–136. doi: 10.1016/j.tig.2011.12.002",
      "volume": "28",
      "year": "2012"
    },
    {
      "DOI": "10.1038/srep04223",
      "author": "J Xu",
      "doi-asserted-by": "publisher",
      "first-page": "4223",
      "journal-title": "Sci Rep",
      "key": "9895_CR3",
      "unstructured": "Xu J, Qian J, Hu Y, Wang J, Zhou X, Chen H, Fang JY (2014) Heterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutations. Sci Rep 4:4223. doi: 10.1038/srep04223",
      "volume": "4",
      "year": "2014"
    },
    {
      "author": "FP Li",
      "first-page": "5358",
      "issue": "18",
      "journal-title": "Cancer Res",
      "key": "9895_CR4",
      "unstructured": "Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48(18):5358–5362",
      "volume": "48",
      "year": "1988"
    },
    {
      "DOI": "10.1136/jmg.38.1.43",
      "author": "A Chompret",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "issue": "1",
      "journal-title": "J Med Genet",
      "key": "9895_CR5",
      "unstructured": "Chompret A, Abel A, Stoppa-Lyonnet D, Brugiéres L, Pagés S, Feunteun J, Bonaïti-Pellié C (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38(1):43–47",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7967",
      "doi-asserted-by": "publisher",
      "key": "9895_CR6",
      "unstructured": "Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, Caron O, Bressac-de Paillerets B, Berthet P, Dugast C, Bonaïti-Pellié C, Stoppa-Lyonnet D, Frébourg T (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27(26):e108-9;author reply e110. doi: 10.1200/JCO.2009.22.7967"
    },
    {
      "DOI": "10.1200/JCO.2014.59.5728",
      "author": "G Bougeard",
      "doi-asserted-by": "publisher",
      "first-page": "2345",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "9895_CR7",
      "unstructured": "Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345–2352. doi: 10.1200/JCO.2014.59.5728",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2009.04.014",
      "author": "A Finkova",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "issue": "1",
      "journal-title": "Cancer Genet Cytogene",
      "key": "9895_CR8",
      "unstructured": "Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z (2009) The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Cancer Genet Cytogene 193(1):63–66. doi: 10.1016/j.cancergencyto.2009.04.014",
      "volume": "193",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.onc.1207951",
      "author": "RS Houlston",
      "doi-asserted-by": "crossref",
      "first-page": "6471",
      "issue": "38",
      "journal-title": "Oncogene",
      "key": "9895_CR9",
      "unstructured": "Houlston RS, Peto J (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene 23(38):6471–6476",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nrclinonc.2014.41",
      "author": "K McBride",
      "doi-asserted-by": "publisher",
      "first-page": "260",
      "issue": "5",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "9895_CR10",
      "unstructured": "McBride K, Ballinger ML, Killick E et al (2014) Li-Fraumeni syndrome: cancer risk assesment and clinical management. Nat Rev Clin Oncol 11(5):260–271. doi: 10.1038/nrclinonc.2014.41",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1044-579X(02)00099-8",
      "author": "D Michael",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "issue": "1",
      "journal-title": "Semin Cancer Biol",
      "key": "9895_CR11",
      "unstructured": "Michael D, Oren M (2003) The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13(1):49–58",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10689-013-9667-2",
      "author": "M Renaux-Petel",
      "doi-asserted-by": "publisher",
      "first-page": "127",
      "issue": "1",
      "journal-title": "Fam cancer",
      "key": "9895_CR12",
      "unstructured": "Renaux-Petel M, Sesboue R, Baert-Desurmont S, Vasseur S, Fourneaux S, Bessenay E, Frébourg T, Bougeard G (2014) The MDM2 285G-309G haplotype is associated with an earlier age of tumor onset in patients with Li Fraumeni Syndrome. Fam cancer 13(1):127–130. doi: 10.1007/s10689-013-9667-2",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-011-0957-1",
      "author": "CC Wu",
      "doi-asserted-by": "crossref",
      "first-page": "663",
      "journal-title": "Hum Genet",
      "key": "9895_CR13",
      "unstructured": "Wu CC, Krahe R, Lozano G, Zhang B, Wilson CD, Jo EJ, Amos CI, Shete S, Strong LC (2011) Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Hum Genet 129:663–673",
      "volume": "129",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0010813",
      "author": "S Fang",
      "doi-asserted-by": "crossref",
      "first-page": "e10813",
      "journal-title": "PLoS ONE",
      "key": "9895_CR14",
      "unstructured": "Fang S, Krahe R, Lozano G, Han Y, Chen W, Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC, Amos CI (2010) Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS ONE 5:e10813",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng1093",
      "author": "P Dumont",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "9895_CR15",
      "unstructured": "Dumont P, Leu JI, Della Pietra AC III, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33(3):357–365",
      "volume": "33",
      "year": "2003"
    },
    {
      "DOI": "10.1186/1471-2407-11-208",
      "author": "Y Wan",
      "doi-asserted-by": "publisher",
      "first-page": "208",
      "journal-title": "BMC Cancer",
      "key": "9895_CR16",
      "unstructured": "Wan Y, Wu W, Yin Z, Guan P, Zhou B (2011) MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. BMC Cancer 11:208. doi: 10.1186/1471-2407-11-208",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1017/S0016672315000075",
      "author": "MH Khan",
      "doi-asserted-by": "publisher",
      "first-page": "e7",
      "journal-title": "Genet Res (Camb)",
      "key": "9895_CR17",
      "unstructured": "Khan MH, Kalil A, Rashid H (2015) Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis. Genet Res (Camb) 97:e7. doi: 10.1017/S0016672315000075",
      "volume": "97",
      "year": "2015"
    },
    {
      "DOI": "10.1128/MCB.06150-11",
      "author": "L Biderman",
      "doi-asserted-by": "publisher",
      "first-page": "1214",
      "issue": "7",
      "journal-title": "Mol Cell Biol",
      "key": "9895_CR18",
      "unstructured": "Biderman L, Poyurovsky MV, Assia Y, Manley JL, Prives C (2012) MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress. Mol Cell Biol 32(7):1214–1225. doi: 10.1128/MCB.06150-11",
      "volume": "32",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201715",
      "author": "MW Ruijs",
      "doi-asserted-by": "crossref",
      "first-page": "110",
      "issue": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "9895_CR19",
      "unstructured": "Ruijs MW, Schmidt MK, Nevanlinna H, Tommiska J, Aittomäki K, Pruntel R, Verhoef S, Van’t Veer LJ (2007) The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes. Eur J Hum Genet 15(1):110–114",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.2174/1568009053332627",
      "author": "GL Bond",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Curr Cancer Drug Targets",
      "key": "9895_CR20",
      "unstructured": "Bond GL, Hu W, Levine AJ (2005) MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets 5(1):3–8",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1073/pnas.95.26.15608",
      "author": "SN Jones",
      "doi-asserted-by": "crossref",
      "first-page": "15608",
      "issue": "26",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9895_CR21",
      "unstructured": "Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A (1998) Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci USA 95(26):15608–15612",
      "volume": "95",
      "year": "1998"
    },
    {
      "author": "C Cordon-Cardo",
      "first-page": "794",
      "issue": "3",
      "journal-title": "Cancer Res",
      "key": "9895_CR22",
      "unstructured": "Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54(3):794–799",
      "volume": "54",
      "year": "1994"
    },
    {
      "author": "FS Leach",
      "first-page": "2231",
      "issue": "10",
      "journal-title": "Cancer Res",
      "key": "9895_CR23",
      "unstructured": "Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B (1993) p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53(10):2231–2234",
      "volume": "53",
      "year": "1993"
    },
    {
      "DOI": "10.3810/jhg.2011.82",
      "author": "MC Epistolato",
      "doi-asserted-by": "publisher",
      "first-page": "685",
      "journal-title": "JMG",
      "key": "9895_CR24",
      "unstructured": "Epistolato MC, Disciglio V, Livide G, Berchialla P, Mencarelli MA, Marozza A, Amenduni M, Hadjistilianou T, De Francesco S, Acquaviva A, Toti P, Cetta F, Ariani F, De Marchi M, Renieri A, Giachino D (2011) p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma. JMG 53:685–686. doi: 10.3810/jhg.2011.82",
      "volume": "53",
      "year": "2011"
    },
    {
      "DOI": "10.1093/jnci/djj054",
      "author": "C Menin",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "issue": "4",
      "journal-title": "J Natl Cancer Inst",
      "key": "9895_CR25",
      "unstructured": "Menin C, Scaini MC, De Salvo GL, Biscuola M, Quaggio M, Esposito G, Belluco C, Montagna M, Agata S, D’Andrea E, Nitti D, Amadori A, Bertorelle R (2006) Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst 98(4):285–288",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-0825",
      "author": "GL Bond",
      "doi-asserted-by": "crossref",
      "first-page": "5481",
      "issue": "13",
      "journal-title": "Cancer Res",
      "key": "9895_CR26",
      "unstructured": "Bond GL, Hu W, Levine A (2005) A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect. Cancer Res 65(13):5481–5484",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1136/jmg.2005.037952",
      "author": "G Bougeard",
      "doi-asserted-by": "crossref",
      "first-page": "531",
      "issue": "6",
      "journal-title": "J Med Genet",
      "key": "9895_CR27",
      "unstructured": "Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L, Chompret A, Bressac-de Paillerets B, Stoppa-Lyonnet D, Bonaiti-Pellie C, Frebourg T (2006) Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J Med Genet 43(6):531–533",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-07-0634",
      "author": "Z Hu",
      "doi-asserted-by": "crossref",
      "first-page": "2717",
      "issue": "12",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9895_CR28",
      "unstructured": "Hu Z, Jin G, Wang L, Chen F, Wang X, Shen H (2007) MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studies. Cancer Epidemiol Biomarkers Prev 16(12):2717–2723",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/djq416",
      "author": "L Castera",
      "doi-asserted-by": "publisher",
      "first-page": "1805",
      "issue": "23",
      "journal-title": "J Natl Cancer Inst",
      "key": "9895_CR29",
      "unstructured": "Castera L, Sabbagh A, Dehainault C, Michaux D, Mansuet-Lupo A et al (2010) MDM2 as a modifier gene in retinoblastoma. J Natl Cancer Inst 102(23):1805–1808. doi: 10.1093/jnci/djq416",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.4161/trns.2.5.16813",
      "author": "S Knappskog",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "issue": "5",
      "journal-title": "Transcription",
      "key": "9895_CR30",
      "unstructured": "Knappskog S, Lønning PE (2011) Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk. Transcription 2(5):207–210. doi: 10.4161/trns.2.5.16813",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ijc.22339",
      "author": "BA Talseth",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "issue": "3",
      "journal-title": "Int J Cancer",
      "key": "9895_CR31",
      "unstructured": "Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ (2007) MDM2 SNP309 T\u003eG alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. Int J Cancer 120(3):563–565",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.18632/oncotarget.1910",
      "author": "S Knappskogg",
      "doi-asserted-by": "crossref",
      "first-page": "8223",
      "issue": "18",
      "journal-title": "Oncotarget",
      "key": "9895_CR32",
      "unstructured": "Knappskogg S, Gansmo LB, Dibirova K et al (2014) Population distribution and ancestry of the cancer protective MDM2 SNP285. Oncotarget 5(18):8223–8234",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ccr.2010.12.019",
      "author": "S Knappskogg",
      "doi-asserted-by": "publisher",
      "first-page": "273",
      "issue": "2",
      "journal-title": "Cancer Cell",
      "key": "9895_CR33",
      "unstructured": "Knappskogg S, Bjørnslett M, Myklebust LM, Huijts PE et al (2011) The MDM2 PromoterSNP285C/309G Haplotype diminishesSp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer Cell 19(2):273–282. doi: 10.1016/j.ccr.2010.12.019",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ijc.27573",
      "author": "BM Ryan",
      "doi-asserted-by": "publisher",
      "first-page": "2710",
      "issue": "11",
      "journal-title": "Int J Cancer",
      "key": "9895_CR34",
      "unstructured": "Ryan BM, Calhoun M, Pine S, Bowman E, Robles A, Ambs S (2012) MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. Int J Cancer 131(11):2710–2716. doi: 10.1002/ijc.27573",
      "volume": "131",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cancergen.2014.12.003",
      "author": "Id Said",
      "doi-asserted-by": "crossref",
      "first-page": "47",
      "issue": "1–2",
      "journal-title": "Cancer Genet.",
      "key": "9895_CR35",
      "unstructured": "Said Id, Malkin D (2015) A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome. Cancer Genet. 208(1–2):47–51",
      "volume": "208",
      "year": "2015"
    },
    {
      "author": "LB Gansmo",
      "first-page": "96",
      "journal-title": "Int J",
      "key": "9895_CR36",
      "unstructured": "Gansmo LB, Knappskog S, Romundstd P, Hveem K, Vatten L, Lonning PE (2015) Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon. Int J 137:96–103",
      "volume": "137",
      "year": "2015"
    }
  ],
  "reference-count": 36,
  "references-count": 36,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-016-9895-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Evaluation of TP53 Pro72Arg and MDM2 SNP285–SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}